**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 629-62-9 |n-Pentadecane | 99 | 211-098-1 |
|----------------|--------------------------------------|----------|-----------|
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
Aspiration hazard. May cause irritation of the digestive tract. May
cause liver damage. May cause central nervous system depression,
characterized by excitement, followed by headache, dizziness,
drowsiness, and nausea. Advanced stages may cause collapse,
unconsciousness, coma and possible death due to respiratory failure.
Aspiration of material into the lungs may cause chemical pneumonitis,
which may be fatal.
Inhalation:
May cause respiratory tract irritation. May cause drowsiness,
unconsciousness, and central nervous system depression.
Chronic:
Chronic inhalation and ingestion may cause effects similar to those
of acute inhalation and ingestion. Prolonged or repeated skin
contact may cause defatting and dermatitis.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid if irritation develops or persists. Flush skin with
plenty of soap and water.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Possible aspiration hazard. Get medical aid.
Inhalation:
Remove from exposure and move to fresh air immediately. Get medical
aid if cough or other symptoms appear.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid
contact with eyes, skin, and clothing. Avoid contact with skin and
eyes. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 629-62-9:
CAS# 90622-53-0:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: Clear
Odor: Not available.
pH: Not available.
Vapor Pressure: 1 mm Hg @ 92 deg C
Viscosity: 37.0
Boiling Point: 270 deg C @ 760.00mm Hg
Freezing/Melting Point: 9.9 deg C
Autoignition Temperature: Not available.
Flash Point: 132 deg C ( 269.60 deg F)
Explosion Limits, lower: 0.45%
Explosion Limits, upper: 6.5%
Decomposition Temperature:
Solubility in water: insoluble
Specific Gravity/Density: .7690g/cm3
Molecular Formula: C15H32
Molecular Weight: 212.42
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 629-62-9: RZ1800000
CAS# 90622-53-0 unlisted.
LD50/LC50:
Not available.
Not available.
Carcinogenicity:
n-Pentadecane -
Not listed by ACGIH, IARC, or NTP.
Alkanes, C12-26-branched and linear -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 629-62-9: No information available.
CAS# 90622-53-0: 0
Canada
CAS# 629-62-9 is listed on Canada's DSL List.
CAS# 629-62-9 is not listed on Canada's Ingredient Disclosure List.
CAS# 90622-53-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 629-62-9 is listed on the TSCA inventory.
CAS# 90622-53-0 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 9/02/1997 Revision #3 Date: 7/09/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2,3-Diethylpyrazine, 98+%
| 15707-24-1 |
|
Solvent green 3
| 128-80-3 |
|
(S)-(+)-1,1'-Binaphthyl-2,2'-Diyl Hydrogen Phosphate, 99%
| 35193-64-7 |
|
Sodium Sulfate Decahydrate
| 7727-73-3 |
|
Cyclohexanecarboxaldehyde, 98%
| 2043-61-0 |
|
Lithium 3,5-diiodosalicylate, 95% (titr. on the dried substance)
| 653-14-5 |
|
m-Toluidine
| 108-44-1 |
|
Pararosaniline (Fuchsin Basic)
| 632-99-5 |
|
N-(1-Pyrenyl)Maleimide, 99%
| 42189-56-0 |
|
3,3',5,5'-Tetramethylbenzidine dihydrochloride hydrate, 98+%
| 64285-73-0 |
|
3-Maleimido-Proxyl, Free Radical
| 5389-27-5 |
|
4-Methoxybenzenesulfonyl Chloride, 99%
| 98-68-0 |
|
L(-)-p-Bromotetramisole oxalate, 99%
| 62284-79-1 |
|
Aq 29s
| 052319-10- |
|
4-Chloro-2-Fluorobenzaldehyde, 99%
| 0-00-1 |
|
n-Pentadecane, 99%
| 629-62-9 |
|
2-Bromo-2',5'-dimethoxyacetophenone, 97%
| 1204-21-3 |
|
d-4-Fluorophenylalanine
| 18125-46-7 |
|
Aq 38d
| |
|
Diphenyliodonium chloride, 97%
| 1483-72-3 |
|
Cobalt Cyclohexanebutyrate
| 38582-17-1 |
|
5-Hydroxy-Isophthalic Acid 99%
| 618-83-7 |
|
L-Serine Ethyl Ester Hydrochloride, 99%
| 26348-61-8 |
|
9-Chlorophenanthrene, 98%
| 947-72-8 |
|
Terephthalic Acid, 98%
| 100-21-0 |
|
7-Ethylindole, 97%
| 22867-74-9 |
|
Trihexylamine, 98%
| 102-86-3 |
|
3,3-Dimethylglutaric Acid, 98%
| 4839-46-7 |
|
Ethylene/vinyl acetate copolymer, 14 wt. % vinyl acetate
| 24937-78-8 |
|
5-Chloro-1,3-dihydro-1-(4-piperidinyl)-2H-benzimidazol-2-one
| 53786-28-0 |
|
4-Methylhippuric acid, 98%
| 27115-50-0 |
|
5,6-Dimethyl-4,7-Dihydroisobenzofuran 99%
| |
|
2',7'-Dichlorofluorescein Diacetate
| 4091-99-0 |
|
Tert-Butyldimethylsilyl Trifluoromethane Sulfonate, 98%
| 69739-34-0 |
|
L-Cysteine Ethyl Ester Hydrochloride 98%
| 868-59-7 |
|
4-Chlorobenzhydrylamine hydrochloride, 98%
| 5267-39-0 |
|
(-)-1,6-Bis(2-Chlorophenyl)-1,6-Diphenyl- 2,4-Hexadiyne-1,6-Diol,
| 86436-20-6 |
|
4-Aminopyridine.HCl Polystyrene Supported 1 MEQ.Chloride/g of PPC, 2%
| 0-00-1 |
|
2-Nitrophenylhydrazine, 97%
| 3034-19-3 |
|
N-Formyl-2-methoxy-piperidine, 97%
| 61020-07-3 |
|
3,5-Dimethylbenzoic Acid, 99%
| 499-06-9 |
|
1,3-Diphenyltriazene
| 136-35-6 |
|
2,3-Dimethyl-1-Butene, 98+%
| 563-78-0 |
|
9-Acetylanthracene, 95%
| 784-04-3 |
|
1,4-Dicyclohexylbenzene, 99%
| 1087-02-1 |
|
1-Pyrrolidinebutanenitrile 97%
| 35543-25-0 |
|
Dimethyl Acetylenedicarboxylate, 98%
| 762-42-5 |
|
Vancomycin hydrochloride, n.l.t. 900 microgram/mg (on dry substance)
| 1404-93-9 |
|
4-Phenylphenol, 97%
| 92-69-3 |
|
Neutron activation standard, long irradiation ii
| |
|
|